CLINICAL_TRIALS
trial_result
· 2020-04-08
Clinical Trial Update: Oxytocin and Affect Processing in Posttraumatic Stress Disorder [Phase 2]
Summary
Phase 2 clinical trial investigating oxytocin effects on affect processing in people with PTSD has completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Posttraumatic Stress Disorder (PTSD) | Phase 2 | Status: COMPLETED | Results posted: 2020-04-08